Faith Abodunrin
Papers
1
Total Citations
1
H-Index
1
About
Faith Abodunrin is a rising oncologist-researcher whose work centers on treatment de-escalation strategies for HPV-positive oropharyngeal squamous cell carcinoma (OPSCC), a cancer with a favorable prognosis that demands careful balancing of efficacy and quality of life. Her major contribution lies in demonstrating that response-adaptive de-escalation—tailoring therapy intensity based on tumor response—can preserve functional outcomes, such as swallowing and speech, without compromising survival. In her pooled analysis of 2025, she synthesized data from multiple trials, showing that patients with HPV-positive OPSCC who underwent de-escalated treatment maintained high survival rates while experiencing reduced long-term toxicity. This work, already cited in early 2025, underscores her impact in shifting clinical practice toward more personalized, less morbid approaches. Abodunrin’s research addresses a critical gap: how to minimize treatment burden in a population with excellent baseline prognosis. Her findings offer a roadmap for future trials and have immediate relevance for clinicians seeking to optimize patient-centered care. As her citation count grows, she is poised to become a key voice in head and neck oncology, championing evidence-based de-escalation that prioritizes both survival and quality of life.
Research Focus
Key Achievements
Top Papers
- 1